Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Representation of Spatiotemporal Information in Human Episodic Memory and Navigation
NCT07423923Phase 1Enrolling by invitation
- Sponsor
- University of Arizona
- Start
- Apr 2025
- Primary completion
- Mar 2030
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of scopolamine, sponsored by University of Arizona. Primary endpoints: Navigational accuracy at 3 days, Intracranial EEG low-frequency oscillatory power at 3 days and 2 more. Started Apr 2025; status: enrolling by invitation.
02
Drugs
scopolamine
Beyond the preview
Go deeper on NCT07423923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07423923.